AXA Framlington Health R Income GBP
GB0005753719
AXA Framlington Health R Income GBP/ GB0005753719 /
NAV01/10/2024 |
Chg.+0.3100 |
Type of yield |
Investment Focus |
Investment company |
32.5400GBP |
+0.96% |
paying dividend |
Equity
Worldwide
|
AXA IM (UK) ▶ |
Investment strategy
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more.
The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company"s financial status, quality of its management, expected profitability and prospects for growth. The Manager has full discretion to select investments for the Fund in line with the above investment policy and in doing so may take into consideration the MSCI World Healthcare index. The MSCI World Healthcare index is designed to measure the performance of large and mid-cap segments across a number of developed markets as selected by the index provider. This index best represents the types of companies in which the Fund predominantly invests.
Investment goal
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more.
Master data
Type of yield: |
paying dividend |
Funds Category: |
Equity |
Region: |
Worldwide |
Branch: |
Sector Health / Pharma |
Benchmark: |
MSCI World Healthcare Total Return Net |
Business year start: |
01/11 |
Last Distribution: |
01/11/2017 |
Depository bank: |
HSBC Bank Plc |
Fund domicile: |
United Kingdom |
Distribution permission: |
United Kingdom |
Fund manager: |
Dani SAURYMPER,Linden Thomson |
Fund volume: |
- |
Launch date: |
27/02/1987 |
Investment focus: |
- |
Conditions
Issue surcharge: |
0.00% |
Max. Administration Fee: |
1.50% |
Minimum investment: |
1,000.00 GBP |
Deposit fees: |
0.70% |
Redemption charge: |
0.00% |
Key Investor Information: |
Download (Print version) |
Investment company
Funds company: |
AXA IM (UK) |
Address: |
7 Newgate Street, EC1A 7NX, London |
Country: |
United Kingdom |
Internet: |
institutional.axa-im.co.uk/
|
Countries
United States of America |
|
65.45% |
Denmark |
|
8.87% |
Switzerland |
|
7.89% |
United Kingdom |
|
5.26% |
France |
|
3.44% |
Germany |
|
2.55% |
Italy |
|
2.09% |
Ireland |
|
1.83% |
Netherlands |
|
1.35% |
Cash |
|
1.27% |
Branches
Pharma/Biotechnology |
|
49.40% |
Healthcare services |
|
22.70% |
Healthcare appliances |
|
21.25% |
Parma, wholesale |
|
4.19% |
Cash |
|
1.27% |
Gesundheitswesen/ Informationstechnologie |
|
1.19% |